Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with variable clinical course characterized by a monoclonal progressive accumulation of mature CD5+ B-lymphocytes avoiding apoptosis. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.